Real-time enrollment status for this diffuse large b-cell lymphoma post-transplant lymphoproliferative disorder clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 9:30 PM UTC
| NCT Number | NCT06672705 |
| Recruiting Status | Recruiting |
| Condition | Diffuse Large B-Cell Lymphoma Post-Transplant Lymphoproliferative Disorder |
| Phase | PHASE1 |
| Target Enrollment | 26 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Timothy Voorhees |
| Last Updated on CT.gov | August 19, 2025 (Aug 19, 2025) |
As of July 17, 2026: Clinical trial NCT06672705 is currently recruiting participants. This phase1 study for diffuse large b-cell lymphoma post-transplant lymphoproliferative disorder is actively seeking new participants at 2 locations across the United States. The study is sponsored by Timothy Voorhees. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06672705 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06672705 was last updated Aug 19, 2025 (August 19, 2025). HelloStudys verifies this status automatically.